Recent Insider Transactions - Emergent BioSolutions (NYSE: EBS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NYSE EBS Emergent BioSolutions

Lowry Simon C / officer: SVP, R&D, CMO

12/15/2024

Buy

$8.48

40,499

$343K

40,499

NYSE EBS Emergent BioSolutions

Glessner Coleen / officer: EVP, Quality & Ethics, and CPL

12/08/2024

Sell

$9.01

18,674

$168K

144,460

NYSE EBS Emergent BioSolutions

DeGolyer Donald W / director

11/12/2024

Sell

$10.91

25,000

$273K

111,100

NYSE EBS Emergent BioSolutions

White Marvin L / director

11/11/2024

Sell

$11.97

14,287

$171K

54,092

NYSE EBS Emergent BioSolutions

Hartzel William / officer: SVP, Bioservices

11/11/2024

Sell

$11.97

632

$8K

47,475

NYSE EBS Emergent BioSolutions

Perl Jessica / officer: SVP, General Counsel, Corp Sec

10/29/2024

Sell

$12.95

15,445

$200K

NYSE EBS Emergent BioSolutions

Perl Jessica / officer: SVP, General Counsel, Corp Sec

10/29/2024

Sell

$2.33

18,000

$42K